HIGHLIGHTS
- who: . et al. from the Southern University of Science and Technology, China have published the research: TRPM4 and TRPV2 are two novel prognostic biomarkers and promising targeted therapy in UVM, in the Journal: (JOURNAL)
- what: This study aimed to identify the potential of TRPs as reliable biomarkers for UVM that can predict patient prognosis and responses to therapy. The authors focused on the expression patterns of individual genes which were highly associated with the expression levels of TRPV2 or TRPM4.
- how: The authors used this database to analyze genes correlation related to TRPV2 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.